Extra-thoracic staging of lung cancer

European Journal of Radiology

Volumn 45, Issue 1, 2003, Pages 31-38

  Pope, Romney J E ^a   Hansell, David M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Computed tomography; Lung cancer; Metastases; Nuclear medicine; Positron emission tomography; Staging

Indexed keywords

IMAGING TECHNIQUES; POSITRON EMISSION TOMOGRAPHY; PULMONARY DISEASES;

EXTRA-THORACIC METASTATIC LUNG CANCER;

RADIOLOGY;

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE;

ADRENAL METASTASIS; BONE SCINTISCANNING; BRAIN METASTASIS; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGING SYSTEM; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; LUNG SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

ADRENAL GLAND NEOPLASMS; BONE NEOPLASMS; BRAIN NEOPLASMS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM METASTASIS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037216419     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(02)00299-1     Document Type: Article

References (40)

1. Kadri M.A., Dussek J.E. Survival and prognosis following resection of primary non small cell bronchogenic carcinoma. Eur. J. Cardiothoracic Surg. 5:(3):1991;132-136.
2. Quint L.E., Francis I.R. Radiologic staging of lung cancer. J. Thorac. Imaging. 14:(4):1999;235-246.
3. Ichinose Y., Hara N., et al. Preoperative examination to detect distant metastasis is not advocated for asymptomatic patients with stages 1 and 2 Non-Small Cell Lung Cancer. Chest. 96:(5):1989;1104-1109.
4. Hatter J., Kohman L.J., Mosca R.S., et al. Preoperative evaluation of stage I and stage II non-small cell lung cancer. Ann. Thorac. Surg. 58:(6):1994;1738-1741.
5. Ferrigno D., Buccheri G. Cranial computed tomography as a part of the initial staging procedure for patients with non-small-cell lung cancer. Chest. 106:(4):1994;1025-1029.
6. Investigating extrathoracic metastastic disease in patients with apparently operable lung cancer. Ann. Thorac. Surg. 71:2001;425-434.
7. Mintz B.J., Tuhrim S., Alexander S., Yang W.C., Shanzers S. Intracranial metastases in the staging of bronchogenic carcinoma. Chest. 86:1984;850-853.
8. Yokoi K., Kamiya N., Matsuguma H., et al. Detection of brain metastases in potentially operable non-small cell lung cancer. A comparison of CT and MRI. Chest. 115:(3):1999;714-719.
9. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomised trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 322:(8):1990;494-500.
10. Sze G., Shin J., et al. Intraparenchymal brain metastases: MR imaging versus contrast-enhanced CT. Radiology. 168:(1):1998;187-194.
11. Marom E.M., McAdams H.P., Erasmus J.J., et al. Staging non-small cell lung cancer with whole body PET. Radiology. 212:1999;803-809.
12. Glazer H.S., Weyman P.J., Sagel S.S., et al. Non functioning adrenal masses: incidental discovery on computed topography. Am. J. Roentgenol. 139:1982;81-85.
13. Pagani J.J. Normal adrenal glands in small cell lung carcinoma: CT-guided biopsy. Am. J. Roentgenol. 140:(5):1983;949-951.
14. Oliver T.W., Bernadino M.E., Miller J.L., et al. Isolated adrenal masses in non-small-cell bronchogenic carcinoma. Radiology. 153:1984;217-218.
15. Ekholm S., Albrechtsson U., Kugelberg J., Tylen U. Computed topography in preoperative staging of bronchogenic carcinoma. J. Comput. Assist. Tomogr. 4:(6):1980;763-765.
16. Hirleman M.T., Yiu-Chiu V.S., Chiu L.C., Schapiro R.L. The resectability of primary lung carcinoma: a diagnostic staging review. J. Comput. Tomogr. 4:(2):1980;146-163.
17. Gillams A., Roberts C.M., Shaw P., Spiro S.G., Goldstraw P. The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer. Clin. Radiol. 46:(1):1992;18-22.
18. Bernadino M.E., Walther M.M., Philips V.M., et al. CT guided adrenal biopsy: accuracy, safety, and indications. Am. J. Roentgenol. 144:1985;66-69.
19. Boland G.W.L., Lee M.J., Scott Gazelle G., et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am. J. Roentgenol. 171:1998;201-204.
20. Boland G.W., Hahn P.F., Pena C., et al. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology. 202:1997;693-696.
21. Korobkin M., Brodeur F.J., Francis I.R., et al. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology. 200:(3):1996;737-742.
22. Boland G.W., Hahn P.F., Pena C., Mueller P.R. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology. 202:(3):1997;693-696.
23. Chezmar J.L., Robin S.M., Nelson R.C., et al. Adrenal masses: characterization with T1 weighted imaging. Radiology. 166:1998;357-359.
24. Krestin G.P., Stenbrick W., Friedman G. Adrenal masses; evaluation with fast echo MR imaging and Gd-DTPA enhanced dynamic studies. Radiology. 171:1989;675-680.
25. Korobkin M., Lombardi T.J., Aisen A.M., et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR Imaging. Radiology. 197:1995;411-418.
26. Pender S.M., Boland G.W., Lee M.J. The incidental non-hyperfunctioning adrenal mass: an imaging algorithm for characterization. Clin. Radiol. 53:(11):1998;796-804.
27. Erasmus J.J., Patz E.F., Page McAdams H., et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxy-glucose positron emission topography. Am. J. Roentgenol. 168:1997;1357-1360.
28. Silverman P.M., O'Malley J., et al. Conspicuity of hepatic metastases on helical CT: effect of different time delays between contrast administration and scanning. Am. J. Roentgenol. 164:1995;619-623.
29. Patz E.F., Erasmus J.J., et al. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology. 212:1999;56-60.
30. Jones E.C., Chezmar J.L., Nelson R.C., Bernadino M.E. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. Am. J. Roentgenol. 158:(3):1992;535-539.
31. Ward J., Naik K.S., Guthrie J.A., et al. Hepatic lesion detection: comparison of MR imaging after the administration of super paramagnetic iron oxide with dual phase CT. Radiology. 210:1999;459-466.
32. Ito K., Mitchell D.G., Outwater E.K., et al. Hepatic lesions: discrimination of non solid benign lesions from solid malignant lesions with heavily T2 weighted fast spin-echo MR Imaging. Radiology. 204:1997;729-737.
33. Mitchell D.G., Kim I., Chang T.S., et al. Chemical shift phase difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest. Radiol. 26:1991;1041-1052.
34. Blomley M.H., Allbrecht T., Cosgrove D.O., Patel N., et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A - early experience. Radiology. 210:1999;409-416.
35. Harvey C.J., Blomley M.J.K., et al. Developments in ultrasound contrast media. Eur. Radiol. 11:2001;675-689.
36. Donato A.T., Ammerman E.G., Sullesta O. Bone scanning in the evaluation of patients with lung cancer. Ann. Thorac. Surg. 27:(4):1979;300-304.
37. Lewis P., Griffin S., et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 344:(8932):1994;1265-1266.
38. Weder W., Schmid R.A., Bruckhaus H., et al. Detection of extra-thoracic metastases by positron emission topography in lung cancer. Ann. Thorac. Surg. 66:1998;886-893.
39. Valk P.E., Pounds T.R., et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann. Thorac. Surg. 60:1995;1573-1582.
40. Van Tinteren H., Hekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assesment of patients with suspected non small-cell lung cancer: the PLUS multicentred randomised trial. Lancet. 359:2002;1388-1393.